Intrinsic Capital Partners (“Intrinsic”) announced the closing of Intrinsic Health Partners, L.P. (the “Fund”), a $102 million growth equity fund that invests in life science and technology businesses focused on the legal cannabis and hemp industries. Industry insiders believe the investment fund is a  multi-decade secular trend, and a rare opportunity to invest in a space where there’s tremendous underlying demand. Intrinsic is the first investment firm to focus on ancillary cannabis and hemp businesses with a team of both experienced institutional investors and life science and technology operators.

Published Ncv Newswire, New Cannabis Ventures, 10/15/2020 16:41:26

Open article: